Ruxolitinib cream is the first FDA-approved JAK inhibitor for skin repigmentation in people with vitiligo, paving the way for additional oral and topical JAK inhibitors to treat this autoimmune ...
DENVER — It is still wise to consider the safety of JAK inhibitors when prescribing these agents in dermatology. However, real-world and other evidence have emerged since a rheumatoid arthritis study ...
The U.S. Food and Drug Administration (FDA) first approved JAK inhibitors in 2012. “JAK inhibitors are the newest to the scene but have proven benefit in terms of reducing pain, improving function, ...
NEW YORK CITY — When data from clinical trials of JAK inhibitors in atopic dermatitis (AD), vitiligo, and other skin diseases are stratified by race, response rates appear to diverge, with both higher ...
Remember Crash Bandicoot? Naughty Dog created the little marsupial that would eventually become Sony's PlayStation poster boy. His first shirtless adventure was so successful it quickly spawned a ...
Dalton Cooper is the Managing Editor of GameRant. Dalton has been writing about video games professionally since 2011 and joined the GameRant team in 2015. Having written thousands of game reviews and ...
The Jak and Daxter series is a household name among platforming fans, getting much love for its madcap adventures imbued with a good dose of action and puzzle-solving. The latest addition to the ...
Jak is back for the third and purportedly final time in Jak 3, the conclusion to Naughty Dog’s best-selling platforming franchise. Last year’s Jak II turned the series right on its ear, replacing the ...
It's been awhile since Jak and Daxter teamed up for a proper adventure. The last true team-up was Jak III in 2004, then there was the "WTF" kart racer known as Jak X, and then the Ottsel struck out on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results